Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration
Clinical trial NCT02305238 · COMPLETED
Trial details
- NCT number
- NCT02305238
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-19
- Primary completion
- 2016-12-22
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.